The European Medicines Agency (EMA) has published a draft Reflection Paper on the use of AI and machine learning (ML) in the medicinal...
Freshfields TQ
Technology quotient - the ability of an individual, team or organization to harness the power of technology
/Passle/5677e7453d947406989fe60a/MediaLibrary/Images/5c7d24e0abdfe80e706a1933/2020-03-31-15-42-53-109-5e8364fd3dccd105b43351fd.jpg)
There are vast amounts of sensitive health data that are being collected, but due to the stringent regulation on the use of such data not...
/Passle/5677e7453d947406989fe60a/MediaLibrary/Images/5715f1c4b00e7e040c278a3f/2021-07-12-14-58-13-183-60ec5885fac91e01e8361e18.jpg)
The European Commission’s publication of a new draft Product Liability Directive (PLD) in September 2022 (see here and here for our...
/Passle/5677e7453d947406989fe60a/MediaLibrary/Images/5715f1c4b00e7e040c278a3f/2021-07-12-14-53-23-164-60ec5763400fb313bc0d0460.jpg)
The rapid development of artificial intelligence (AI) systems has brought and will continue to bring transformative changes to various...
The Federal Trade Commission (FTC) is ramping up its enforcement activities in the context of companies sharing health data for...
Last month, the UK Government published its inaugural MedTech Strategy, the latest in the Government’s efforts to implement the Life...
Note: This article originally ran in MedCity News We expect 2023 to be a pivotal year for the industry, as the accelerated acceptance of...
The Association of the British Pharmaceutical Industry (ABPI) has published its analysis of the UK’s genomics offering, following the...
In brief: NHS England has published its long-awaited Genomics Strategy (the Strategy), which sets out its ambitions for the acceleration...
“Only by securing people’s confidence and support can we do all of the ambitious, innovative, life-changing things with data that are...
In brief: The UK government-commissioned ‘Equity in medical devices: Independent review’ panel has launched a call for evidence to...
The UK government has recently published a summary of public responses to its Call for Evidence, which it launched in February with the...